Kyu-Shik Jeong (DVM, Ph.D., D.KCVP, D.KSTP) is a renowned veterinary pathologist and stem cell researcher from South Korea with over four decades of academic, clinical, and research experience. He earned his Doctor of Veterinary Medicine and Ph.D. from Kyungpook National University, Korea, and has held prestigious research positions at the NIH and National Cancer Institute (USA), among others. Jeong served as a professor at Kyungpook National University and currently holds positions as Professor and Director at Hoseo University’s Regenerative Medicine Institute and CTO of both EHL Biotechnology Institute and Stellamed Co., Ltd. His research focuses on veterinary pathology, stem cell therapy, and regenerative medicine, with over 325 publications and 80+ patents to his name. He is actively involved in international scientific societies, has served on editorial boards of major journals, and received numerous awards including the Distinguished Scholar Award and the Asian Society of Veterinary Pathology Academic Award. Dr. Jeong also leads various advisory boards and has supervised more than 140 students and researchers.

Jeimylo Cristobal de Castro, MD, FPARM, DPBRM, RMSK, DAABRM, CIPS is a distinguished Filipino physiatrist and international expert in musculoskeletal ultrasound, regenerative medicine, and interventional pain management. A Diplomate and Fellow of the Philippine Academy of Rehabilitation Medicine (PARM) and a board-certified specialist in Regenerative Medicine (AABRM-USA), he is internationally certified in Musculoskeletal Sonography (RMSK) and Interventional Pain Sonology (CIPS).
Dr. de Castro is the Medical Director of SMARTMD Center for Non-Surgical and Regenerative Therapies and of PuRXCell Philippines. He has served as the former Chair of Physical Medicine and Rehabilitation at The Medical City–South Luzon and is a founding director of the Philippine Academy of Lifestyle Medicine (PALM). He is also pursuing doctoral studies in Preventive Care at Loma Linda University, USA.
 

Dr. Bidemi Emmanuel Ekundayo brings expertise in biochemistry, neurodegeneration, and pharmacological science to our editorial team. As a faculty member at Bamidele Olumilua University of Science and Technology, he has authored impactful work on Alzheimer’s disease mechanisms, neuroprotective roles of vitamins and plant compounds, and oxidative stress models in disease. With a solid publication track record—including both empirical studies and comprehensive reviews—and growing scholarly impact, he is well positioned to contribute thoughtfully to manuscript evaluation, thematic guidance, and the strategic direction of the journal.

I have been actively involved in Biomedical research for more than two decades with expertise in molecular biology, immunology, and oncology. My ongoing research is focused on understanding the role of tumor microenvironment with special focus on stem cells and immune status in influencing the phenotypic and functional heterogeneity in haematological malignancies. We are using single cell transcriptomics to obtain a better understanding of Acute Myeloid Leukemia (AML) pathogenesis and chemo-resistance, especially the role of leukemic stem cells that contribute to high rate of relapse in AML. In parallel, another research focus is on the potential use of minimally invasive plasma-derived circulating tumor DNA (ctDNA) as a biomarker for real-time disease monitoring in AML. This may facilitate better prognostic risk stratification, options for targeted therapy, MRD assessment and relapse prediction in AML. Moreover, the genotype guided risk classification of AML with concurrent evaluation of immune phenotype in AML patients using cell free nucleic acids (ctDNA and circulating cell free RNA) is being investigated as a novel approach for disease monitoring that may facilitate the design of preclinical and early clinical studies of immunotherapeutic combinations for precision medicine in AML.